COMPARISON OF 2 MEDICATIONS IN CENTRAL-NERVOUS-SYSTEM TOXOPLASMOSIS IN PATIENTS WITH AIDS
被引:6
作者:
ANTINORI, A
论文数: 0引用数: 0
h-index: 0
机构:Istituto di Clinica delle Malattie Infettive, Università Cattolica del Sacro Cuore, Roma, 8-00168, Largo Gemelli
ANTINORI, A
AMMASSARI, A
论文数: 0引用数: 0
h-index: 0
机构:Istituto di Clinica delle Malattie Infettive, Università Cattolica del Sacro Cuore, Roma, 8-00168, Largo Gemelli
AMMASSARI, A
MAIURO, G
论文数: 0引用数: 0
h-index: 0
机构:Istituto di Clinica delle Malattie Infettive, Università Cattolica del Sacro Cuore, Roma, 8-00168, Largo Gemelli
MAIURO, G
CAMILLI, G
论文数: 0引用数: 0
h-index: 0
机构:Istituto di Clinica delle Malattie Infettive, Università Cattolica del Sacro Cuore, Roma, 8-00168, Largo Gemelli
CAMILLI, G
DAMIANO, F
论文数: 0引用数: 0
h-index: 0
机构:Istituto di Clinica delle Malattie Infettive, Università Cattolica del Sacro Cuore, Roma, 8-00168, Largo Gemelli
DAMIANO, F
FEDERICO, G
论文数: 0引用数: 0
h-index: 0
机构:Istituto di Clinica delle Malattie Infettive, Università Cattolica del Sacro Cuore, Roma, 8-00168, Largo Gemelli
FEDERICO, G
PIZZIGALLO, E
论文数: 0引用数: 0
h-index: 0
机构:Istituto di Clinica delle Malattie Infettive, Università Cattolica del Sacro Cuore, Roma, 8-00168, Largo Gemelli
PIZZIGALLO, E
TAMBURRINI, E
论文数: 0引用数: 0
h-index: 0
机构:Istituto di Clinica delle Malattie Infettive, Università Cattolica del Sacro Cuore, Roma, 8-00168, Largo Gemelli
TAMBURRINI, E
机构:
[1] Istituto di Clinica delle Malattie Infettive, Università Cattolica del Sacro Cuore, Roma, 8-00168, Largo Gemelli
[2] Cattedra di Malattie Infettive, Università 'G. D'Annunzio', Chieti
来源:
ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES
|
1992年
/
13卷
/
06期
关键词:
TOXOPLASMOSIS;
PYRIMETHAMINE;
SULFADIAZINE;
D O I:
10.1007/BF02230867
中图分类号:
R74 [神经病学与精神病学];
学科分类号:
摘要:
We retrospectively examined 39 patients with AIDS and central nervous system toxoplasmosis in order to determine the efficacy and safety of two combinations: pyrimethamine-sulfadiazine and pyrimethamine-clindamycin. The results showed a response rate of 79% for the sulfadiazine association and a high failure rate in the clindamycin group. Side effects with sulfadiazine were slightly more frequent, but with desensitization protocols discontinuation was kept down. The combination of pyrimethamine and sulfadiazine, associated, when necessary, with desensitization schedules, was confirmed to be first choice therapy for cerebral toxoplasmosis in AIDS patients. The role of alternative regimens needs further evaluation.